Active, Not Recruiting
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
NCT06436742
- Conditions
- CMS, Congenital Myasthenic Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +5 more
- Locations
-
- UC Davis Medical Center Sacramento, California, United States
- Ann and Robert H Lurie Childrens Hospital of Chicago Chicago, Illinois, United States
- Ottawa Hospital Research Institute - Civic Campus Ottawa, Canada
- CHU - Hospital de la Timone Marseille, France